Mark Rosenblum
Director of Finance/CFO chez SALARIUS PHARMACEUTICALS, INC.
Fortune : 11 559 $ au 31/03/2024
Profil
Mark J.
Rosenblum currently works at The American Institute of Certified Public Accountants, as Member and Salarius Pharmaceuticals, Inc., as Chief Financial Officer & Executive Vice President from 2019.
Mr. Rosenblum also formerly worked at ActiveCare, Inc., as Chairman & Chief Executive Officer from 2017 to 2019, Wellman, Inc., as Chief Accounting Officer, VP & Controller from 1985 to 2003, Hemobiotech, Inc., as Chief Financial Officer & Secretary from 2005 to 2009, Advaxis, Inc., as Chief Financial Officer, Secretary & Senior VP from 2010 to 2014, South Carolina Association of Certified Public Accountants, as Member, and Vaneltix Pharma, Inc., as Chief Financial Officer from 2014 to 2015.
Mr. Rosenblum received his undergraduate degree and graduate degree from the University of South Carolina.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/03/2024 | 21 851 ( 0,51% ) | 11 559 $ | 31/03/2024 |
Postes actifs de Mark Rosenblum
| Sociétés | Poste | Début |
|---|---|---|
| SALARIUS PHARMACEUTICALS, INC. | Director of Finance/CFO | 10/09/2019 |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Corporate Officer/Principal | - |
Anciens postes connus de Mark Rosenblum
| Sociétés | Poste | Fin |
|---|---|---|
| ACTIVECARE INC | Chief Executive Officer | 01/03/2019 |
Vaneltix Pharma, Inc.
 Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ. | Director of Finance/CFO | 01/07/2015 |
| AYALA PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/04/2014 |
Hemobiotech, Inc.
 Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Director of Finance/CFO | 31/12/2009 |
Wellman, Inc.
 Wellman, Inc. Chemicals: SpecialtyProcess Industries Wellman, Inc. manufactures plastic packaging, fibers and engineering resins. Its resins are used in the manufacture of plastic beverage bottles and food packaging products, as well as used for CSD and high temperature filling applications. The company is headquartered in Fort Mill, SC. | Comptroller/Controller/Auditor | 01/06/2003 |
Formation de Mark Rosenblum
| University of South Carolina | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Wellman, Inc.
Wellman, Inc. Chemicals: SpecialtyProcess Industries Wellman, Inc. manufactures plastic packaging, fibers and engineering resins. Its resins are used in the manufacture of plastic beverage bottles and food packaging products, as well as used for CSD and high temperature filling applications. The company is headquartered in Fort Mill, SC. | Process Industries |
Hemobiotech, Inc.
Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Health Technology |
ActiveCare, Inc.
 ActiveCare, Inc. Medical SpecialtiesHealth Technology ActiveCare, Inc. engages in the provision of provides self-insured health plans with solutions that reduce the impact and cost of diabetes. The compnay was founded on March 5, 1998 and is headquartered in Salt Lake City, UT. | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Commercial Services |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
| South Carolina Association of Certified Public Accountants | |
Vaneltix Pharma, Inc.
Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ. | Health Technology |
| Salarius Pharmaceuticals, Inc. |
